Purpose of the development: It is used in a planned abdominal delivery.

Recommended application field: Medicine, blood transfusion services, health care facilities.

Advantages over analogues: Reinfusion of autologous blood and atutoplazmy with a planned caesarean section provides in the postoperative period it a smoother flow. The women included in the program autodonorstva, 2-3 times less than in patients without replacement gene therapy, developed purulent-septic complications. Eksfuziya blood or plasma neokazyvaet negative impact on the status of the fetus.

The development stage readiness: Introduced in production

Description of the development:
()
All pregnant women with a planned caesarean section to a targeted survey to assess the possibility of including them in the program autodonorstva. Pregnant women at high risk for the development of major bleeding (placenta previa, a scar on the uterus, multiple pregnancy, polyhydramnios, bleeding in the previous birth), it is advisable to backup autoplasma. eksfuziya whole blood of 400 ml and a plasma volume of 300 ± 20 ml in women in the III trimester of pregnancy did not cause changes in blood parameters, parapmetrov central hemodynamics in normotensive women and has a positive effect on pregnant women with hypertension caused by preeclampsia. Aprbirovano health facilities in the country, Republican Scientific Center of the blood, a research institute of obstetrics, gynecology and pediatrics.

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Tajikistan

For additional information turn to:
E-mail: gal@uintei.kiev.ua